The antiviral activity of MxB was first reported in 2013 (11, –, 13), when it was shown that the human MxB (huMxB) protein plays a crucial role in blocking human immunodeficiency virus type 1 (HIV-1) infection in interferon-induced human cells. This evidence concerns the gene MX2 and HIV-1 infection.